Exact Mass: 385.2114

Exact Mass Matches: 385.2114

Found 62 metabolites which its exact mass value is equals to given mass value 385.2114, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Echitamine

CID 11953926

C22H29N2O4+ (385.2127)


   

Vernakalant hydrochloride

Vernakalant (Hydrochloride)

C20H32ClNO4 (385.202)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent C93038 - Cation Channel Blocker

   

4'-Hydroxycilostazol, trans-

6-{4-[1-(4-hydroxycyclohexyl)-1H-1,2,3,4-tetrazol-5-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one

C20H27N5O3 (385.2114)


   

Bamifylline

8-benzyl-7-{2-[ethyl(2-hydroxyethyl)amino]ethyl}-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C20H27N5O3 (385.2114)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Propioxatin B

Propioxatin B

C18H31N3O6 (385.2213)


   

BAMIFYLLINE

BAMIFYLLINE

C20H27N5O3 (385.2114)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

JWH-098

JWH-098

C26H27NO2 (385.2042)


   

DTXSID101017821

DTXSID101017821

C26H27NO2 (385.2042)


   

DTXSID401017820

DTXSID401017820

C26H27NO2 (385.2042)


   

prolylasparagylarginine

prolylasparagylarginine

C15H27N7O5 (385.2074)


   

Arg Pro Asn

Arg Pro Asn

C15H27N7O5 (385.2074)


   

Pro Arg Asn

Pro Arg Asn

C15H27N7O5 (385.2074)


   

Echitamine

Echitamine

[C22H29N2O4]+ (385.2127)


   

Gly Gly Pro Arg

(2S)-2-{[(2S)-1-[2-(2-aminoacetamido)acetyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C15H27N7O5 (385.2074)


   

Gly Gly Arg Pro

(2S)-1-[(2S)-2-[2-(2-aminoacetamido)acetamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C15H27N7O5 (385.2074)


   

Gly Pro Gly Arg

(2S)-2-(2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}acetamido)-5-carbamimidamidopentanoic acid

C15H27N7O5 (385.2074)


   

Gly Pro Arg Gly

2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]acetic acid

C15H27N7O5 (385.2074)


   

Gly Arg Gly Pro

(2S)-1-{2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H27N7O5 (385.2074)


   

Gly Arg Pro Gly

2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C15H27N7O5 (385.2074)


   

Asn Arg Pro

Asn Arg Pro

C15H27N7O5 (385.2074)


   

Pro Gly Gly Arg

(2S)-5-carbamimidamido-2-(2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}acetamido)pentanoic acid

C15H27N7O5 (385.2074)


   

Pro Gly Arg Gly

2-[(2S)-5-carbamimidamido-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]acetic acid

C15H27N7O5 (385.2074)


   

Pro Arg Gly Gly

2-{2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}acetic acid

C15H27N7O5 (385.2074)


   

Arg Asn Pro

Arg Asn Pro

C15H27N7O5 (385.2074)


   

Arg Gly Gly Pro

(2S)-1-(2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}acetyl)pyrrolidine-2-carboxylic acid

C15H27N7O5 (385.2074)


   

Arg Gly Pro Gly

2-{[(2S)-1-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetyl}pyrrolidin-2-yl]formamido}acetic acid

C15H27N7O5 (385.2074)


   

Arg Pro Gly Gly

2-(2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)acetic acid

C15H27N7O5 (385.2074)


   

Asn Pro Arg

Asn Pro Arg

C15H27N7O5 (385.2074)


   

Pro Asn Arg

Pro Asn Arg

C15H27N7O5 (385.2074)


   

JWH098

JWH098

C26H27NO2 (385.2042)


   

JWH 210 N-(5-hydroxypentyl)

JWH 210 N-(5-hydroxypentyl)

C26H27NO2 (385.2042)


   

JWH 210 N-(4-hydroxypentyl) metabolite

JWH 210 N-(4-hydroxypentyl) metabolite

C26H27NO2 (385.2042)


   

(4S,5S)-1,3-DIMETHYL-4,5-DIPHENYL-2-[(R)-1-BENZYL-2-HYDROXYETHYLIMINO]IMIDAZOLIDINE

(4S,5S)-1,3-DIMETHYL-4,5-DIPHENYL-2-[(R)-1-BENZYL-2-HYDROXYETHYLIMINO]IMIDAZOLIDINE

C25H27N3O (385.2154)


   

1-Chloro-5-Fluoropentane

1-Chloro-5-Fluoropentane

C25H27N3O (385.2154)


   

4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-[1,1-Biphenyl]-2-carbonitrile

4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-[1,1-Biphenyl]-2-carbonitrile

C25H27N3O (385.2154)


   

(4R,5S)-1-BENZYL-4-(4-FLUORO-PHENYL)-5-HYDROXYMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID TERT-BUTYL ESTER

(4R,5S)-1-BENZYL-4-(4-FLUORO-PHENYL)-5-HYDROXYMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID TERT-BUTYL ESTER

C23H28FNO3 (385.2053)


   

2-(7-Methoxy-1-naphthyl)-N-[2-(7-methoxy-1-naphthyl)ethyl]ethanamine

2-(7-Methoxy-1-naphthyl)-N-[2-(7-methoxy-1-naphthyl)ethyl]ethanamine

C26H27NO2 (385.2042)


   

bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine

bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine

C26H27NO2 (385.2042)


   

tert-Butyl 4-acetyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 4-acetyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C21H28BNO5 (385.206)


   

Methylsamidorphan

Methylsamidorphan

C22H29N2O4+ (385.2127)


C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

6-(2,4-Diamino-6-ethylpyrimidin-5-YL)-4-(3-methoxypropyl)-2,2-dimethyl-2H-1,4-benzoxazin-3(4H)-one

6-(2,4-Diamino-6-ethylpyrimidin-5-YL)-4-(3-methoxypropyl)-2,2-dimethyl-2H-1,4-benzoxazin-3(4H)-one

C20H27N5O3 (385.2114)


   

N-[(3S)-3-hydroxy-4-oxo-4-(propylamino)butanoyl]-L-isoleucyl-L-proline

N-[(3S)-3-hydroxy-4-oxo-4-(propylamino)butanoyl]-L-isoleucyl-L-proline

C18H31N3O6 (385.2213)


   

3-Hydroxy-16-methoxy-2,3-dihydrotabersoninium

3-Hydroxy-16-methoxy-2,3-dihydrotabersoninium

C22H29N2O4+ (385.2127)


An indole alkaloid cation that is the conjugate acid of 3-hydroxy-16-methoxy-2,3-dihydrotabersonine, obtained by protonation of the tertiary amino function; major species at pH 7.3.

   

deacetylvindorosine

deacetylvindorosine

C22H29N2O4+ (385.2127)


   

1-[2-(Diethylamino)ethyl]-7,7-dimethyl-2-(4-methylphenyl)-5,8-dihydropyrano[4,3-d]pyrimidine-4-thione

1-[2-(Diethylamino)ethyl]-7,7-dimethyl-2-(4-methylphenyl)-5,8-dihydropyrano[4,3-d]pyrimidine-4-thione

C22H31N3OS (385.2188)


   

3-[(2-Adamantylamino)-oxomethyl]-1-methylsulfonyl-1-pentylurea

3-[(2-Adamantylamino)-oxomethyl]-1-methylsulfonyl-1-pentylurea

C18H31N3O4S (385.2035)


   

N-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]acetamide

N-[(cyclohexylamino)-oxomethyl]-2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]acetamide

C20H27N5O3 (385.2114)


   

Pro-Asn-Arg

Pro-Asn-Arg

C15H27N7O5 (385.2074)


   

[(2S,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-[(propan-2-ylamino)methyl]-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methanol

[(2S,3S,4S)-1-(4-ethyl-1,3-thiazol-2-yl)-4-[(propan-2-ylamino)methyl]-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methanol

C22H31N3OS (385.2188)


   

4-[4-[(1S,5R)-3-[cyclohexyl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

4-[4-[(1S,5R)-3-[cyclohexyl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H27N3O (385.2154)


   

[(2R,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-[(propan-2-ylamino)methyl]-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methanol

[(2R,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-[(propan-2-ylamino)methyl]-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methanol

C22H31N3OS (385.2188)


   

[(2S,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-[(propan-2-ylamino)methyl]-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methanol

[(2S,3R,4R)-1-(4-ethyl-1,3-thiazol-2-yl)-4-[(propan-2-ylamino)methyl]-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methanol

C22H31N3OS (385.2188)


   

Methyl (1S,9R,10S,12S,15R)-13-ethenyl-10-hydroxy-18-(hydroxymethyl)-15-methyl-8-aza-15-azoniapentacyclo[10.5.1.01,9.02,7.09,15]octadeca-2,4,6-triene-18-carboxylate

Methyl (1S,9R,10S,12S,15R)-13-ethenyl-10-hydroxy-18-(hydroxymethyl)-15-methyl-8-aza-15-azoniapentacyclo[10.5.1.01,9.02,7.09,15]octadeca-2,4,6-triene-18-carboxylate

C22H29N2O4+ (385.2127)


   

Arg-Asn-Pro

Arg-Asn-Pro

C15H27N7O5 (385.2074)


   

Asn-Arg-Pro

Asn-Arg-Pro

C15H27N7O5 (385.2074)


   

Asn-Pro-Arg

Asn-Pro-Arg

C15H27N7O5 (385.2074)


   

Pro-Arg-Asn

Pro-Arg-Asn

C15H27N7O5 (385.2074)


   

Arg-Pro-Asn

Arg-Pro-Asn

C15H27N7O5 (385.2074)


   

(1s,9r,10s,12s,13e,15s,18s)-13-ethylidene-10-hydroxy-18-(hydroxymethyl)-18-(methoxycarbonyl)-15-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-trien-15-ium

(1s,9r,10s,12s,13e,15s,18s)-13-ethylidene-10-hydroxy-18-(hydroxymethyl)-18-(methoxycarbonyl)-15-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-trien-15-ium

[C22H29N2O4]+ (385.2127)


   

(2r)-2-({[(2r)-1-[(2r)-3-(dihydroxycarbonimidoyl)-2-(2-methylpropyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-methylbutanoic acid

(2r)-2-({[(2r)-1-[(2r)-3-(dihydroxycarbonimidoyl)-2-(2-methylpropyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-methylbutanoic acid

C18H31N3O6 (385.2213)


   

(2s)-2-({[(2s)-1-[(2r)-3-(dihydroxycarbonimidoyl)-2-(2-methylpropyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-methylbutanoic acid

(2s)-2-({[(2s)-1-[(2r)-3-(dihydroxycarbonimidoyl)-2-(2-methylpropyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-methylbutanoic acid

C18H31N3O6 (385.2213)


   

(1s,9r,12r,18r)-13-ethylidene-10-hydroxy-18-(hydroxymethyl)-18-(methoxycarbonyl)-15-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-trien-15-ium

(1s,9r,12r,18r)-13-ethylidene-10-hydroxy-18-(hydroxymethyl)-18-(methoxycarbonyl)-15-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-trien-15-ium

[C22H29N2O4]+ (385.2127)